Two Protective Preconditioning Methods Used Different Cannabinoid-Related Mechanisms in Rat Brain Slices

NMDA and DHPG preconditioning both reduced vulnerability to later injury in rat hippocampal slices, but CB1 blockade disrupted only the DHPG-related protection. Similar protective outcomes did not establish a shared mechanism.

The preparation was an organotypic slice

The investigators used rat hippocampal tissue and experimental excitotoxic or oxygen-and-glucose-deprivation insults. The term tolerance described resistance to subsequent injury. It did not refer to diminished intoxication after repeated cannabis use, and the preparation was not a human stroke-treatment trial.

Protein and electrophysiological findings diverged

NMDA preconditioning reduced the measured GluA1 protein component, consistent with AMPA-receptor internalization, whereas DHPG did not produce that same protein result. Both procedures reduced later AMPA-induced currents. A similar electrical endpoint therefore did not require identical changes in the assessed receptor protein.

Lipid-pathway probes narrowed the interpretation

AM251 prevented DHPG-induced protection but not NMDA-induced protection. A MAG-lipase inhibitor also induced protection, whereas the tested FAAH inhibitor did not. These comparisons supported a role for 2-AG in the DHPG mechanism rather than treating all endocannabinoids as interchangeable.

Interpreting the evidence

The experiment separates injury resistance, receptor trafficking and endocannabinoid pathways. It does not show that THC reproduces the preconditioning response or establish a clinical method of preventing brain injury.

Related reading: central and peripheral endocannabinoid-enzyme interventions.

Research reference

Gerace E; Zianni E; Landucci E; et al. (2020). Differential mechanisms of tolerance induced by NMDA and 3,5-dihydroxyphenylglycine (DHPG) preconditioning. Journal of neurochemistry. doi:10.1111/jnc.15033. Evidence basis: report abstract.